By Adrian Wildfire, Director of Scientific and Business Strategy at hVIVO COVID-19 vaccine distribution has been operational on a global scale since December 2020 and infection rates have dropped in relation to the pace and extent of the roll-out. While COVID-19 vaccines have proven effective against the early viruses, researchers are still studying how well they protect against new, more resistant SARS-CoV-2 strains.
Adrian Wildfire
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Adrian
Contact Adrian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack